Episode 327: Loss to Follow-Up in Diabetic Retinopathy and Academic Advancement with Dr. Lisa Schocket

Dr. Lisa Schocket joins to discuss loss to follow-up in diabetic retinopathy and potential future trials and solutions, as well as developing an academic career. Relevant Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Allergan, Dorc, Genentech, and Regeneron. Dr. Schocket PENDING.You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi